Overview

Phase II Study of ZD6474 in Advanced NSCLC

Status:
Terminated
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn how the drug ZD6474 affects the amount of tumor cell death in the body and the amount of blood that can be supplied to the tumor. The safety of ZD6474 alone and when given with chemotherapy will be studied. In addition, the side effects and response to this treatment will also be studied.
Phase:
Phase 2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborator:
AstraZeneca
Treatments:
Albumin-Bound Paclitaxel
Carboplatin
Paclitaxel